カテゴリー： Market Monitor Global, 世界, 医療/バイオ

カスタムアデノ随伴ウイルスベクター作製サービスのグローバル市場展望 2023年-2029年：小規模、中規模、大規模

◆英語タイトル：Custom Adeno-associated Viral Vector Production Service Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12318）

◆商品コード：MMG23DC12318
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のカスタムアデノ随伴ウイルスベクター作製サービス市場規模と予測を収録しています。・世界のカスタムアデノ随伴ウイルスベクター作製サービス市場：売上、2018年-2023年、2024年-2029年
・世界のカスタムアデノ随伴ウイルスベクター作製サービス市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のカスタムアデノ随伴ウイルスベクター作製サービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「小規模」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

カスタムアデノ随伴ウイルスベクター作製サービスのグローバル主要企業は、Esco Aster、 Vector Biolabs、 Syd Labs、 SIRION Biotech、 Biovian、 AGC Biologics、 SignaGen Laboratories、 Takara Bio、 Curia、 Andelyn Biosciences、 EPFL、 BPS Bioscience、 AMSBIO、 Boster Bio、 Creative Biogene、 Thermo Fisher Scientificなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、カスタムアデノ随伴ウイルスベクター作製サービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のカスタムアデノ随伴ウイルスベクター作製サービス市場：タイプ別、2018年-2023年、2024年-2029年
世界のカスタムアデノ随伴ウイルスベクター作製サービス市場：タイプ別市場シェア、2022年
・小規模、中規模、大規模

世界のカスタムアデノ随伴ウイルスベクター作製サービス市場：用途別、2018年-2023年、2024年-2029年
世界のカスタムアデノ随伴ウイルスベクター作製サービス市場：用途別市場シェア、2022年
・遺伝子治療、細胞治療、医薬品研究開発、その他

世界のカスタムアデノ随伴ウイルスベクター作製サービス市場：地域・国別、2018年-2023年、2024年-2029年
世界のカスタムアデノ随伴ウイルスベクター作製サービス市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるカスタムアデノ随伴ウイルスベクター作製サービスのグローバル売上、2018年-2023年
・主要企業におけるカスタムアデノ随伴ウイルスベクター作製サービスのグローバル売上シェア、2022年
・主要企業におけるカスタムアデノ随伴ウイルスベクター作製サービスのグローバル販売量、2018年-2023年
・主要企業におけるカスタムアデノ随伴ウイルスベクター作製サービスのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Esco Aster、 Vector Biolabs、 Syd Labs、 SIRION Biotech、 Biovian、 AGC Biologics、 SignaGen Laboratories、 Takara Bio、 Curia、 Andelyn Biosciences、 EPFL、 BPS Bioscience、 AMSBIO、 Boster Bio、 Creative Biogene、 Thermo Fisher Scientific

*************************************************************

・調査・分析レポートの概要
カスタムアデノ随伴ウイルスベクター作製サービス市場の定義
市場セグメント
世界のカスタムアデノ随伴ウイルスベクター作製サービス市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のカスタムアデノ随伴ウイルスベクター作製サービス市場規模
世界のカスタムアデノ随伴ウイルスベクター作製サービス市場規模：2022年 VS 2029年
世界のカスタムアデノ随伴ウイルスベクター作製サービス市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのカスタムアデノ随伴ウイルスベクター作製サービスの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のカスタムアデノ随伴ウイルスベクター作製サービス製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：小規模、中規模、大規模
カスタムアデノ随伴ウイルスベクター作製サービスのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：遺伝子治療、細胞治療、医薬品研究開発、その他
カスタムアデノ随伴ウイルスベクター作製サービスの用途別グローバル売上・予測

・地域別市場分析
地域別カスタムアデノ随伴ウイルスベクター作製サービス市場規模 2022年と2029年
地域別カスタムアデノ随伴ウイルスベクター作製サービス売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Esco Aster、 Vector Biolabs、 Syd Labs、 SIRION Biotech、 Biovian、 AGC Biologics、 SignaGen Laboratories、 Takara Bio、 Curia、 Andelyn Biosciences、 EPFL、 BPS Bioscience、 AMSBIO、 Boster Bio、 Creative Biogene、 Thermo Fisher Scientific
...

This research report provides a comprehensive analysis of the Custom Adeno-associated Viral Vector Production Service market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Custom Adeno-associated Viral Vector Production Service market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Custom Adeno-associated Viral Vector Production Service, challenges faced by the industry, and potential opportunities for market players.
The global Custom Adeno-associated Viral Vector Production Service market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Custom Adeno-associated Viral Vector Production Service market presents opportunities for various stakeholders, including Gene Therapy, Cell Therapy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Custom Adeno-associated Viral Vector Production Service market. Additionally, the growing consumer demand present avenues for market expansion.
The global Custom Adeno-associated Viral Vector Production Service market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Custom Adeno-associated Viral Vector Production Service market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Custom Adeno-associated Viral Vector Production Service market.
Market Overview: The report provides a comprehensive overview of the Custom Adeno-associated Viral Vector Production Service market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Small-scale, Medium-scale), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Custom Adeno-associated Viral Vector Production Service market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Custom Adeno-associated Viral Vector Production Service market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Custom Adeno-associated Viral Vector Production Service market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Custom Adeno-associated Viral Vector Production Service market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Custom Adeno-associated Viral Vector Production Service market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Custom Adeno-associated Viral Vector Production Service market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Custom Adeno-associated Viral Vector Production Service, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Custom Adeno-associated Viral Vector Production Service market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Custom Adeno-associated Viral Vector Production Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Small-scale
Medium-scale
Large-scale
Market segment by Application
Gene Therapy
Cell Therapy
Drug Research & Development
Others
Global Custom Adeno-associated Viral Vector Production Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Esco Aster
Vector Biolabs
Syd Labs
SIRION Biotech
Biovian
AGC Biologics
SignaGen Laboratories
Takara Bio
Curia
Andelyn Biosciences
EPFL
BPS Bioscience
AMSBIO
Boster Bio
Creative Biogene
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Custom Adeno-associated Viral Vector Production Service, market overview.
Chapter 2: Global Custom Adeno-associated Viral Vector Production Service market size in revenue.
Chapter 3: Detailed analysis of Custom Adeno-associated Viral Vector Production Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Custom Adeno-associated Viral Vector Production Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Custom Adeno-associated Viral Vector Production Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Custom Adeno-associated Viral Vector Production Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Custom Adeno-associated Viral Vector Production Service Overall Market Size
2.1 Global Custom Adeno-associated Viral Vector Production Service Market Size: 2022 VS 2029
2.2 Global Custom Adeno-associated Viral Vector Production Service Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Custom Adeno-associated Viral Vector Production Service Players in Global Market
3.2 Top Global Custom Adeno-associated Viral Vector Production Service Companies Ranked by Revenue
3.3 Global Custom Adeno-associated Viral Vector Production Service Revenue by Companies
3.4 Top 3 and Top 5 Custom Adeno-associated Viral Vector Production Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Custom Adeno-associated Viral Vector Production Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Custom Adeno-associated Viral Vector Production Service Players in Global Market
3.6.1 List of Global Tier 1 Custom Adeno-associated Viral Vector Production Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Custom Adeno-associated Viral Vector Production Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Custom Adeno-associated Viral Vector Production Service Market Size Markets, 2022 & 2029
4.1.2 Small-scale
4.1.3 Medium-scale
4.1.4 Large-scale
4.2 By Type – Global Custom Adeno-associated Viral Vector Production Service Revenue & Forecasts
4.2.1 By Type – Global Custom Adeno-associated Viral Vector Production Service Revenue, 2018-2023
4.2.2 By Type – Global Custom Adeno-associated Viral Vector Production Service Revenue, 2024-2029
4.2.3 By Type – Global Custom Adeno-associated Viral Vector Production Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Custom Adeno-associated Viral Vector Production Service Market Size, 2022 & 2029
5.1.2 Gene Therapy
5.1.3 Cell Therapy
5.1.4 Drug Research & Development
5.1.5 Others
5.2 By Application – Global Custom Adeno-associated Viral Vector Production Service Revenue & Forecasts
5.2.1 By Application – Global Custom Adeno-associated Viral Vector Production Service Revenue, 2018-2023
5.2.2 By Application – Global Custom Adeno-associated Viral Vector Production Service Revenue, 2024-2029
5.2.3 By Application – Global Custom Adeno-associated Viral Vector Production Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Custom Adeno-associated Viral Vector Production Service Market Size, 2022 & 2029
6.2 By Region – Global Custom Adeno-associated Viral Vector Production Service Revenue & Forecasts
6.2.1 By Region – Global Custom Adeno-associated Viral Vector Production Service Revenue, 2018-2023
6.2.2 By Region – Global Custom Adeno-associated Viral Vector Production Service Revenue, 2024-2029
6.2.3 By Region – Global Custom Adeno-associated Viral Vector Production Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Custom Adeno-associated Viral Vector Production Service Revenue, 2018-2029
6.3.2 US Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.3.3 Canada Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.3.4 Mexico Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Custom Adeno-associated Viral Vector Production Service Revenue, 2018-2029
6.4.2 Germany Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.4.3 France Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.4.4 U.K. Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.4.5 Italy Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.4.6 Russia Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.4.7 Nordic Countries Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.4.8 Benelux Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Custom Adeno-associated Viral Vector Production Service Revenue, 2018-2029
6.5.2 China Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.5.3 Japan Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.5.4 South Korea Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.5.5 Southeast Asia Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.5.6 India Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Custom Adeno-associated Viral Vector Production Service Revenue, 2018-2029
6.6.2 Brazil Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.6.3 Argentina Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Custom Adeno-associated Viral Vector Production Service Revenue, 2018-2029
6.7.2 Turkey Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.7.3 Israel Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.7.4 Saudi Arabia Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
6.7.5 UAE Custom Adeno-associated Viral Vector Production Service Market Size, 2018-2029
7 Custom Adeno-associated Viral Vector Production Service Companies Profiles
7.1 Esco Aster
7.1.1 Esco Aster Company Summary
7.1.2 Esco Aster Business Overview
7.1.3 Esco Aster Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.1.4 Esco Aster Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.1.5 Esco Aster Key News & Latest Developments
7.2 Vector Biolabs
7.2.1 Vector Biolabs Company Summary
7.2.2 Vector Biolabs Business Overview
7.2.3 Vector Biolabs Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.2.4 Vector Biolabs Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.2.5 Vector Biolabs Key News & Latest Developments
7.3 Syd Labs
7.3.1 Syd Labs Company Summary
7.3.2 Syd Labs Business Overview
7.3.3 Syd Labs Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.3.4 Syd Labs Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.3.5 Syd Labs Key News & Latest Developments
7.4 SIRION Biotech
7.4.1 SIRION Biotech Company Summary
7.4.2 SIRION Biotech Business Overview
7.4.3 SIRION Biotech Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.4.4 SIRION Biotech Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.4.5 SIRION Biotech Key News & Latest Developments
7.5 Biovian
7.5.1 Biovian Company Summary
7.5.2 Biovian Business Overview
7.5.3 Biovian Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.5.4 Biovian Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.5.5 Biovian Key News & Latest Developments
7.6 AGC Biologics
7.6.1 AGC Biologics Company Summary
7.6.2 AGC Biologics Business Overview
7.6.3 AGC Biologics Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.6.4 AGC Biologics Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.6.5 AGC Biologics Key News & Latest Developments
7.7 SignaGen Laboratories
7.7.1 SignaGen Laboratories Company Summary
7.7.2 SignaGen Laboratories Business Overview
7.7.3 SignaGen Laboratories Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.7.4 SignaGen Laboratories Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.7.5 SignaGen Laboratories Key News & Latest Developments
7.8 Takara Bio
7.8.1 Takara Bio Company Summary
7.8.2 Takara Bio Business Overview
7.8.3 Takara Bio Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.8.4 Takara Bio Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.8.5 Takara Bio Key News & Latest Developments
7.9 Curia
7.9.1 Curia Company Summary
7.9.2 Curia Business Overview
7.9.3 Curia Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.9.4 Curia Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.9.5 Curia Key News & Latest Developments
7.10 Andelyn Biosciences
7.10.1 Andelyn Biosciences Company Summary
7.10.2 Andelyn Biosciences Business Overview
7.10.3 Andelyn Biosciences Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.10.4 Andelyn Biosciences Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.10.5 Andelyn Biosciences Key News & Latest Developments
7.11 EPFL
7.11.1 EPFL Company Summary
7.11.2 EPFL Business Overview
7.11.3 EPFL Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.11.4 EPFL Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.11.5 EPFL Key News & Latest Developments
7.12 BPS Bioscience
7.12.1 BPS Bioscience Company Summary
7.12.2 BPS Bioscience Business Overview
7.12.3 BPS Bioscience Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.12.4 BPS Bioscience Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.12.5 BPS Bioscience Key News & Latest Developments
7.13 AMSBIO
7.13.1 AMSBIO Company Summary
7.13.2 AMSBIO Business Overview
7.13.3 AMSBIO Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.13.4 AMSBIO Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.13.5 AMSBIO Key News & Latest Developments
7.14 Boster Bio
7.14.1 Boster Bio Company Summary
7.14.2 Boster Bio Business Overview
7.14.3 Boster Bio Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.14.4 Boster Bio Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.14.5 Boster Bio Key News & Latest Developments
7.15 Creative Biogene
7.15.1 Creative Biogene Company Summary
7.15.2 Creative Biogene Business Overview
7.15.3 Creative Biogene Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.15.4 Creative Biogene Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.15.5 Creative Biogene Key News & Latest Developments
7.16 Thermo Fisher Scientific
7.16.1 Thermo Fisher Scientific Company Summary
7.16.2 Thermo Fisher Scientific Business Overview
7.16.3 Thermo Fisher Scientific Custom Adeno-associated Viral Vector Production Service Major Product Offerings
7.16.4 Thermo Fisher Scientific Custom Adeno-associated Viral Vector Production Service Revenue in Global Market (2018-2023)
7.16.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ カスタムアデノ随伴ウイルスベクター作製サービスのグローバル市場展望 2023年-2029年：小規模、中規模、大規模(Custom Adeno-associated Viral Vector Production Service Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

カスタムアデノ随伴ウイルスベクター作製サービスのグローバル市場展望 2023年-2029年：小規模、中規模、大規模

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp